One of the largest annual clinical audits in the world. It measures the effectiveness of diabetes healthcare against NICE Clinical Guidelines and NICE Quality Standards in England and Wales, for both primary and secondary care.
This summary data set contains data from the other NCRAS data sets as well as some fields taken from Hospital Episode Statistics (HES), Diagnostic Imaging Data Set (DIDs) and Cancer Waiting Times (CWT) data.
This data set contains information about patients diagnosed with registerable tumour in the calendar years from 1995 onward. Data is submitted by skilled cancer registration officers from locations where cancer care takes place.
This data set contains information about patients diagnosed with a registerable tumour in the calendar years 1985 to 1994. It is very limited and applicants wishing to process this data must first discuss their requirements with the NDRS team to confirm whether the data set can be used for their request.
This audit looks at the care delivered during referral, diagnosis, treatment and outcomes for people diagnosed with lung cancer and mesothelioma.
This data set contains information from clinical audits carried out at specific points in time, focusing on the diagnostic pathway for patients diagnosed with cancer.
CPES was commissioned by NHS England to collect information via a survey directly from patients with a primary diagnosis of cancer about their experiences. The survey aims to collect information from patients about their experience of the cancer journey from their initial GP visit prior to diagnosis, through diagnosis and treatment and to the ongoing management of their cancer
This audit data set follows on from the LUCADA data, beginning in 2015.
This data set contains information about patients diagnosed with cancer in the calendar year 1995 onwards, with radiotherapy treatment details available from 1 April 2009 onwards.
This data set is from a pilot of Patient Reported Outcome Measures (PROMs) data collected in 2011-12, based on a questionnaire distributed to a representative sample of patients with four different tumour types.
This data set contains responses to a questionnaire distributed to colorectal cancer patients in January 2013, with over 34,000 responses collected.
TIn response to the COVID-19 pandemic, NDRS developed new methodologies to identify new tumours for the period 2018 onwards using existing routine data sources, without the requirement for manual registration of new primary tumours.
This data set begins in 2016 and is ongoing. It contains somatic molecular testing data collected directly from molecular diagnostics laboratories in England. The data covers tests for genetic mutations occurring only in the tumour. Data is received from molecular diagnostic laboratories in England. The data set includes information about the number, type and date of tests for each gene tested.
This data set contains information about patients treated with chemotherapy from April 2012 onward (data prior to July 2014 has some completeness issues). It contains clinical details about anti-cancer therapies and includes information such as the date when a decision to treat was made, treatment cycle dates, and treatment regimen outcome.